一代与二代酪氨酸激酶抑制剂联合化疗序贯异基因造血干细胞移植治疗Ph(+)急性淋巴细胞白血病疗效比较

OBJECTIVE: To investigate the efficacy of sequential treatment with first-line administration of second-generation tyrosine kinase inhibitors (TKI) and first-generation TKI (imatinib) in patients with Ph(+) acute lymphoblastic leukemia (Ph(+) ALL) followed by allogeneic hematopoietic stem cell trans...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Zhonghua Xue Ye Xue Za Zhi
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Editorial office of Chinese Journal of Hematology 2018
Pynciau:
论著
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7342571/
https://ncbi.nlm.nih.gov/pubmed/29562444
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.02.007
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg